1. Home
  2. KRYS vs UCB Comparison

KRYS vs UCB Comparison

Compare KRYS & UCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRYS
  • UCB
  • Stock Information
  • Founded
  • KRYS 2015
  • UCB 1950
  • Country
  • KRYS United States
  • UCB United States
  • Employees
  • KRYS N/A
  • UCB N/A
  • Industry
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • UCB
  • Sector
  • KRYS Health Care
  • UCB
  • Exchange
  • KRYS Nasdaq
  • UCB NYSE
  • Market Cap
  • KRYS 3.6B
  • UCB 3.4B
  • IPO Year
  • KRYS 2017
  • UCB 2002
  • Fundamental
  • Price
  • KRYS $125.96
  • UCB $28.72
  • Analyst Decision
  • KRYS Strong Buy
  • UCB Hold
  • Analyst Count
  • KRYS 8
  • UCB 5
  • Target Price
  • KRYS $211.13
  • UCB $33.00
  • AVG Volume (30 Days)
  • KRYS 436.2K
  • UCB 501.9K
  • Earning Date
  • KRYS 05-06-2025
  • UCB 07-23-2025
  • Dividend Yield
  • KRYS N/A
  • UCB 3.34%
  • EPS Growth
  • KRYS 109.01
  • UCB 38.09
  • EPS
  • KRYS 4.16
  • UCB 2.11
  • Revenue
  • KRYS $333,448,000.00
  • UCB $907,594,000.00
  • Revenue This Year
  • KRYS $48.66
  • UCB $17.51
  • Revenue Next Year
  • KRYS $49.81
  • UCB $6.14
  • P/E Ratio
  • KRYS $30.31
  • UCB $13.62
  • Revenue Growth
  • KRYS 247.53
  • UCB 12.08
  • 52 Week Low
  • KRYS $122.80
  • UCB $22.93
  • 52 Week High
  • KRYS $219.34
  • UCB $35.38
  • Technical
  • Relative Strength Index (RSI)
  • KRYS 31.65
  • UCB 52.55
  • Support Level
  • KRYS $123.03
  • UCB $28.55
  • Resistance Level
  • KRYS $127.59
  • UCB $29.21
  • Average True Range (ATR)
  • KRYS 4.59
  • UCB 0.52
  • MACD
  • KRYS 0.39
  • UCB -0.11
  • Stochastic Oscillator
  • KRYS 18.15
  • UCB 37.75

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

About UCB UNITED COMMUNITY BANKS(GEORGIA)

United Community Banks Inc provides a wide range of financial products and services to the commercial, retail, governmental, educational, energy, health care and real estate sectors. This includes a variety of deposit products, secured and unsecured loans, mortgage loans, payment and commerce solutions, equipment finance services, wealth management, trust services, private banking, investment advisory services, insurance services, and other related financial services. These products and services are delivered through a variety of channels including its branches, other offices, the Internet, and mobile applications. It operates as a locally-focused community bank, supplemented by experienced, centralized support to deliver products and services to its larger, more sophisticated, customers.

Share on Social Networks: